ORAGENICS, INC. Sale of Stock, Price Per Share
ORAGENICS, INC. (OGEN) had Sale of Stock, Price Per Share of $0.00 per share as of 2018-04-06, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2018-11-13
- 2018-04-06: Sale of Stock, Price Per Share $0.00.
- 2012-07-30: Sale of Stock, Price Per Share $1.50.
| Period end | Sale of Stock, Price Per Share |
|---|---|
| 2018-04-06 | $0.00 10-Q · filed 2018-11-13 |
| 2012-07-30 | $1.50 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |